Calcitonin secretion in postmenopausal osteoporosis

Area of Science:

• Endocrinology
• Bone Metabolism
• Osteoporosis Research

Background:

• Calcitonin deficiency is a suspected cause of accelerated bone loss in postmenopausal osteoporosis.
• Previous studies have implicated low calcitonin levels in the pathogenesis of osteoporosis.

Purpose of the Study:

• To investigate the role of calcitonin in postmenopausal osteoporosis.
• To determine if calcitonin deficiency is associated with accelerated bone loss in postmenopausal women.

Main Methods:

• Studied 25 postmenopausal osteoporotic patients, 14 healthy controls, and 5 thyroidectomy patients.
• Administered intravenous calcium infusion to assess calcitonin secretory reserve.
• Measured calcitonin levels using radioimmunoassay in plasma and plasma extracts for enhanced sensitivity.

Main Results:

• Basal calcitonin concentrations were significantly higher in osteoporotic patients compared to healthy controls.
• Calcitonin secretory reserve after calcium stimulation was normal in osteoporotic patients.
• Thyroidectomy patients showed a near-absent calcitonin secretory reserve.

Conclusions:

• Postmenopausal osteoporosis is not associated with or caused by calcitonin deficiency.
• Elevated basal calcitonin in osteoporosis may indicate increased calcitonin secretion in response to skeletal calcium release.